GXP PHARMAID ApS: Financial statements 2016
CVR: 29615861
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,632,757 and a net result of DKK 97,377 compared with DKK -667,129 the year before. That is a decrease of 13.9% compared with the year before. Equity in the 2016 report amounted to DKK 544,395. The solvency ratio was 35.4%.
- Gross Profit
- DKK 1,632,757
- Profit/Loss
- DKK 97,377
- Equity
- DKK 544,395
- Total Assets
- DKK 1,539,425
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 1.6 mio. | 97 t. | 544 t. | - |
| 2015 | - | 1.9 mio. | -667 t. | 447 t. | - |
| 2014 | - | 3.6 mio. | 380 t. | 1.1 mio. | - |
| 2013 | - | 2.3 mio. | 451 t. | 1.1 mio. | - |
| 2012 | - | 2.1 mio. | - | - | - |
Official annual report
Find more companies like GXP PHARMAID ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
GXP PHARMAID ApS has published its annual report for 2015. Gross profit came to DKK 1,896,044, and the net result was DKK -667,129.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.